|
|
 |
|
Viewing report
|
|
|
|
Aastrom Biosciences, Inc. (ASTM) - Financial and Strategic SWOT Analysis Review
GlobalData, April 2012, Pages: 94
Aastrom Biosciences, Inc. (ASTM) - Financial and Strategic SWOT Analysis Review
Summary
Aastrom Biosciences (Aastrom) is a development stage regenerative medicine company, which is involved in autologous cell products for use in regenerative medicine. The company’s principal business is to develop innovative cell therapies based products for use in multiple therapeutic areas like, cardiac and vascular. The company’s preclinical and clinical product development programs investigate the ability of patient-derived bone marrow stem and early progenitor cell populations to aid in regeneration of body tissues.
The company aims to continually develop and add new high-quality products to its wide range of product catalogue, as well as increase validation of its current products with a stringent focus on data collection and presentation. Aastrom is headquartered in Michigan, the US.
Aastrom Biosciences, Inc. Key Recent Developments
Mar 14, 2012: Aastrom Biosciences Appoints LaVonne Lang As Head Of Regulatory Affairs
Mar 12, 2012: Aastrom Biosciences Reports Q4 2011 Results
Nov 08, 2011: Aastrom Biosciences Reports Q3 2011 Results
Oct 13, 2011: Aastrom Appoints Brian Gibson As Vice President, Finance
Aug 15, 2011: Aastrom Reports Q2 2011 Financial Results
This comprehensive SWOT profile of Aastrom Biosciences, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Aastrom Biosciences, Inc. - Product Pipeline Review - Q4 2010
Aastrom Biosciences, Inc. - Product Pipeline Review - Q4 2010
Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review
Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review
GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review
Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review
MultiCell Technologies, Inc. (MCET) - Financial and Strategic SWOT Analysis Review
Apricus Bioscience Inc (APRI) - Financial and Strategic SWOT Analysis Review
Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review
DARA BioSciences, Inc. (DARA) - Financial and Strategic SWOT Analysis Review
|
|
|
|
